-
Je něco špatně v tomto záznamu ?
Drug-polymer compatibility prediction via COSMO-RS
A. Mathers, M. Fulem
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- farmaceutická chemie metody MeSH
- léčivé přípravky chemie MeSH
- polymery chemie MeSH
- povidon * chemie MeSH
- rozpouštědla chemie MeSH
- rozpustnost MeSH
- uvolňování léčiv MeSH
- Publikační typ
- časopisecké články MeSH
In this work, the solid-liquid equilibrium (SLE) curve for ten active pharmaceutical ingredients (APIs) with the polymer polyvinylpyrrolidone (PVP) K12 was purely predicted using the Conductor-like Screening Model for Real Solvents (COSMO-RS). In particular, two COSMO-RS-based strategies were followed (i.e., a traditional approach and an expedited approach), and their performances were compared. The veracity of the predicted SLE curves was assessed via a comparison with their respective SLE dataset that was obtained using the step-wise dissolution (S-WD) method. Overall, the COSMO-RS-based API-PVP K12 SLE curves were in satisfactory agreement with the S-WD-based data points. Of the twenty predicted SLE curves, only two were found to be in strong disagreement with the corresponding experimental values (both modeled using the expedited approach). Hence, it was recommended to use the traditional approach when predicting the API-polymer SLE curve. At the present moment, COSMO-RS may be an effective computational tool for the expeditious screening of API-polymer compatibility, particularly in the case of promising novel APIs, for which experimental datasets are likely limited or non-existent.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018696
- 003
- CZ-PrNML
- 005
- 20241024111222.0
- 007
- ta
- 008
- 241015e20240822ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2024.124613 $2 doi
- 035 __
- $a (PubMed)39179010
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mathers, Alex $u Department of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic
- 245 10
- $a Drug-polymer compatibility prediction via COSMO-RS / $c A. Mathers, M. Fulem
- 520 9_
- $a In this work, the solid-liquid equilibrium (SLE) curve for ten active pharmaceutical ingredients (APIs) with the polymer polyvinylpyrrolidone (PVP) K12 was purely predicted using the Conductor-like Screening Model for Real Solvents (COSMO-RS). In particular, two COSMO-RS-based strategies were followed (i.e., a traditional approach and an expedited approach), and their performances were compared. The veracity of the predicted SLE curves was assessed via a comparison with their respective SLE dataset that was obtained using the step-wise dissolution (S-WD) method. Overall, the COSMO-RS-based API-PVP K12 SLE curves were in satisfactory agreement with the S-WD-based data points. Of the twenty predicted SLE curves, only two were found to be in strong disagreement with the corresponding experimental values (both modeled using the expedited approach). Hence, it was recommended to use the traditional approach when predicting the API-polymer SLE curve. At the present moment, COSMO-RS may be an effective computational tool for the expeditious screening of API-polymer compatibility, particularly in the case of promising novel APIs, for which experimental datasets are likely limited or non-existent.
- 650 12
- $a povidon $x chemie $7 D011205
- 650 _2
- $a léčivé přípravky $x chemie $7 D004364
- 650 _2
- $a polymery $x chemie $7 D011108
- 650 _2
- $a rozpouštědla $x chemie $7 D012997
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a farmaceutická chemie $x metody $7 D002626
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fulem, Michal $u Department of Physical Chemistry, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic. Electronic address: fulemm@vscht.cz
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 664 (20240822), s. 124613
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39179010 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111216 $b ABA008
- 999 __
- $a ok $b bmc $g 2201525 $s 1230669
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 664 $c - $d 124613 $e 20240822 $i 1873-3476 $m International journal of pharmaceutics $n Int J Pharm $x MED00002359
- LZP __
- $a Pubmed-20241015